EUVIMEDEUVIMED entdecken
Crossref

Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer

Oskar Franklin, Thomas F Stoop, Salvador Rodriguez Franco, Toshitaka Sugawara, Hiroyuki Ishida, Asif Halimi, Kathryn Colborn, Ana Gleisner, Richard D Schulick, Marco Del Chiaro

Pancreatology · 2026

DOI: 10.1016/j.pan.2025.12.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2026. Verfasst von Oskar Franklin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Department of Diagnostics and Inter…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Svenska Läkaresällskapet, American College of Surgeons, Royal Swedish Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Treatment options for pancreatic cancer with major arterial involvement has evolved in the last decades with the introduction of multi-agent chemotherapies. This study aimed to explore treatment patterns of surgical and oncological treatment for clinical stage T4 pancreatic cancer in the United States. METHODS: The study included clinical T4M0 pancreatic cancer cases treated between 2004 and 2021 in the US National Cancer Database. Treatment patterns and overall survival were evaluated and divided into three time periods (2004-2010, 2011-2016, 2017-2021). Odds of resection were assessed with multivariable logistic regression. RESULTS: In total, 47,345 cases were analyzed, of which 4222 (8.9 %) underwent surgery. The median age was 68 years, 49 % were male and 77.0 % reported non-hispanic white race. The proportion of patients that received no treatment decreased from 31.2 % to 23.6 % and the proportion that received both chemotherapy and surgery increased from 4.4 % to 11.1 %. Among patients that received upfront chemotherapy (n = 28,445), single-agent chemotherapy dominated in 2004 but was almost completely replaced by multi-agent chemotherapy by 2021. Median overall survival improved; for non-resected patients from 10.8 months in 2004-2010 to 14.9 months in 2017-2021 (p < .001), and for resected patients from 25.2 to 32.7 months (p < .001). Variables associated with higher odds of resection included private insurance and center volume, whereas age, race/ethnicity, clinical N1-2 and a body/tail tumor location was associated with lower odds. CONCLUSIONS: Treatment for pancreatic cancer with major arterial involvement has shifted towards an increased use of multi-agent chemotherapy and surgical resection, with an associated improved overall survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansMaleAgedFemaleMiddle AgedUnited StatesAged, 80 and overPancreatectomyDatabases, FactualAdultNeoplasm Staging

Autor:innen und Institutionen

  • Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Department of Diagnostics and Intervention, Surgery, Umeå University, Sweden.
  • Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cance…
  • Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Department of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan; Department…
  • Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Department of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Diagnostics and Intervention, Surgery, Umeå University, Sweden.

Förderung

  • Svenska Läkaresällskapet
  • American College of Surgeons
  • Royal Swedish Academy of Sciences

Zitieren

APA

Franklin, O., Stoop, T. F., Rodriguez Franco, S., Sugawara, T., Ishida, H., Halimi, A., Colborn, K., Gleisner, A., Schulick, R. D., & Del Chiaro, M. (2026). Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer. Pancreatology. https://doi.org/10.1016/j.pan.2025.12.007

Vancouver

Franklin O, Stoop TF, Rodriguez Franco S, Sugawara T, Ishida H, Halimi A, et al. Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer. Pancreatology. 2026. doi:10.1016/j.pan.2025.12.007

BibTeX
@article{Franklin2026,
  author = {Franklin, Oskar and Stoop, Thomas F and Rodriguez Franco, Salvador and Sugawara, Toshitaka and Ishida, Hiroyuki and Halimi, Asif and Colborn, Kathryn and Gleisner, Ana and Schulick, Richard D and Del Chiaro, Marco},
  title = {Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer},
  journal = {Pancreatology},
  year = {2026},
  doi = {10.1016/j.pan.2025.12.007}
}
Kostenlos starten →